Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 343243

Changing from a first to second generation of ifosfamide.based regimen (from IMVP to ICE) does not improve outcome of patients with relapsed or refractory aggressive NHL


Aurer, Igor; Mitrović, Zdravko; Nemet, Damir; Radman, Ivo; Setrtić, Dubravka; Serventi Seiwerth, Ranka; Štern Padovan, Ranka; Šantek, Fedor; Nola, Marin; Mrsić, Mirando; Labar, Boris.
Changing from a first to second generation of ifosfamide.based regimen (from IMVP to ICE) does not improve outcome of patients with relapsed or refractory aggressive NHL // Hematologica
Beč, Austrija, 2007. (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 343243 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Changing from a first to second generation of ifosfamide.based regimen (from IMVP to ICE) does not improve outcome of patients with relapsed or refractory aggressive NHL

Autori
Aurer, Igor ; Mitrović, Zdravko ; Nemet, Damir ; Radman, Ivo ; Setrtić, Dubravka ; Serventi Seiwerth, Ranka ; Štern Padovan, Ranka ; Šantek, Fedor ; Nola, Marin ; Mrsić, Mirando ; Labar, Boris.

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Hematologica / - , 2007

Skup
12th Congress of the European Hematology Association

Mjesto i datum
Beč, Austrija, 07.06.2007. - 10.06.2007

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Non-Hodgkin's lymphoma; ifosfamide-based regimens

Sažetak
Changing from the first generation ifosfamide based regimen , such as IMVP, to a second generation regimen, such as ICE, does not substantially improve outcomes of patients with relapsed or refractory aggressive NHL

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
108-1081872-2061 - LIMFOPROLIFERATIVNE BOLESTI I TRANSPLANTACIJA KRVOTVORNIH MATIČNIH STANICA (Nemet, Damir, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Zagreb


Citiraj ovu publikaciju:

Aurer, Igor; Mitrović, Zdravko; Nemet, Damir; Radman, Ivo; Setrtić, Dubravka; Serventi Seiwerth, Ranka; Štern Padovan, Ranka; Šantek, Fedor; Nola, Marin; Mrsić, Mirando; Labar, Boris.
Changing from a first to second generation of ifosfamide.based regimen (from IMVP to ICE) does not improve outcome of patients with relapsed or refractory aggressive NHL // Hematologica
Beč, Austrija, 2007. (poster, međunarodna recenzija, sažetak, znanstveni)
Aurer, I., Mitrović, Z., Nemet, D., Radman, I., Setrtić, D., Serventi Seiwerth, R., Štern Padovan, R., Šantek, F., Nola, M., Mrsić, M. & Labar, B. (2007) Changing from a first to second generation of ifosfamide.based regimen (from IMVP to ICE) does not improve outcome of patients with relapsed or refractory aggressive NHL. U: Hematologica.
@article{article, author = {Aurer, Igor and Mitrovi\'{c}, Zdravko and Nemet, Damir and Radman, Ivo and Setrti\'{c}, Dubravka and Serventi Seiwerth, Ranka and \v{S}tern Padovan, Ranka and \v{S}antek, Fedor and Nola, Marin and Mrsi\'{c}, Mirando and Labar, Boris.}, year = {2007}, pages = {360}, keywords = {Non-Hodgkin's lymphoma, ifosfamide-based regimens}, title = {Changing from a first to second generation of ifosfamide.based regimen (from IMVP to ICE) does not improve outcome of patients with relapsed or refractory aggressive NHL}, keyword = {Non-Hodgkin's lymphoma, ifosfamide-based regimens}, publisherplace = {Be\v{c}, Austrija} }
@article{article, author = {Aurer, Igor and Mitrovi\'{c}, Zdravko and Nemet, Damir and Radman, Ivo and Setrti\'{c}, Dubravka and Serventi Seiwerth, Ranka and \v{S}tern Padovan, Ranka and \v{S}antek, Fedor and Nola, Marin and Mrsi\'{c}, Mirando and Labar, Boris.}, year = {2007}, pages = {360}, keywords = {Non-Hodgkin's lymphoma, ifosfamide-based regimens}, title = {Changing from a first to second generation of ifosfamide.based regimen (from IMVP to ICE) does not improve outcome of patients with relapsed or refractory aggressive NHL}, keyword = {Non-Hodgkin's lymphoma, ifosfamide-based regimens}, publisherplace = {Be\v{c}, Austrija} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font